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Abstract
Monocytic cells exhibit a high level of heterogeneity and have two distinct modes of their activation: 1) classical M1 path
associated with inflammation and tissue damage, and 2) alternative M2 path. Although it has been demonstrated that M2
macrophages play an important role in the regulation of the allergic immune responses, tissue maintenance and repair, little
is known about the mechanisms that determine the M2 phenotype. We have previously shown that miR-124 is expressed in
microglia that exhibit the M2 phenotype and overexpression of miR-124 in macrophages resulted in downregulation of a
number of M1 markers (MHC class II, CD86) and up-regulation of several M2 markers (Fizz1, Arg1). We further investigated
whether the polarization of macrophages towards the M2 phenotype induced miR-124 expression. We found that exposure
of cells to IL-4 and IL-13 resulted in the upregulation of miR-124 in macrophages. We also demonstrated that IL-4 induced
expression of three miR-124 precursor transcripts with predominant expression of pri-miR-124.3, suggesting regulation of
miR-124 expression by IL-4 on a transcriptional level. Expression of miR-124 in microglia did not depend on IL-4 and/or IL-13,
whereas expression of miR-124 in lung resident macrophages was IL-4 and IL-13-dependent and was upregulated by
systemic administration of IL-4 or during allergic inflammation. Upregulation of several M2 markers (CD206, Ym1) and
downregulation of the M1 markers (CD86, iNOS, TNF) in M2-polarized macrophages was abrogated by a miR-124 inhibitor,
suggesting that this microRNA contributed to the M2 phenotype development and maintenance. Finally we showed that
human CD14+CD16+ intermediate monocytes, which are found in increased numbers in patients with allergies and
bronchial asthma, expressed high levels of miR-124 and exhibited other properties of M2-like cells. Thus, our study suggests
that miR-124 serves as a regulator of the M2 polarization in various subsets of monocytic cells both in vitro and in vivo.
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Introduction
Monocytic cells represent a complex and heterogeneous
population of cells that include tissue resident macrophages nested
in various tissues including the central nervous system (CNS),
peritoneum, lungs, liver, and adipose tissue [1]. In addition to the
tissue resident macrophages, there is a mobile population of
monocytes circulating in the peripheral blood that have an ability
to transmigrate into tissues during inflammation and differentiate
to the inflammatory macrophages [2]. It was shown that under
homeostatic conditions circulating monocytes could also transmi-
grate into tissues to replenish the pool of the tissue resident
macrophages [2]; however it was recently suggested that the
reservoir of the tissue macrophages is supplied by the local
proliferation of the resident cells rather than the egress of
monocytic cells from the blood [3]. The circulating monocytes
appeared to be also a heterogeneous population of cells, especially
in humans, where three distinct subsets were identified: the
classical CD14++CD162, the intermediate CD14+CD16+, and the
non-classical CD14lowCD16+ monocytes [4,5].
There are two major pathways of the macrophage activation
required for their main functional activities: the classical M1
pathway and the alternative M2 pathway [1,6]. The classical
pathway gives rise to the M1 macrophages during an immune
response to infection and is mediated by the Th1 cytokine IFN-c
and the toll-like receptor agonists, such as LPS. The classically
activated M1 macrophages express and secrete large amounts of
potent pro-inflammatory mediators such as TNF and reactive
oxygen species (such as NO) that are associated with substantial
tissue damage. Moreover, the M1 macrophages express high levels
of MHC class II and, co-stimulatory molecules, such as CD86,
which are important for the activation and stimulation of CD4 T
cells. The alternatively activated M2 macrophages are induced by
the Th2-derived cytokines IL-4 or IL-13 (IL-4/IL-13-induced
phenotype is also called the ‘‘M2a’’ subset of M2 population) and
to some extent by the cytokines produced by Tregs, such as IL-10
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or TGF-b (IL-10/TGF-b-induced phenotype is also called ‘‘M2b’’
subset of M2 population). The M2 macrophages produce a
number of factors that are responsible for the anti-parasitic
response and promote tissue repair such as Fizz1, Ym1, Arg1,
Mannose Receptor (MR or CD206) as well as anti-inflammatory,
regulatory, and B cell-stimulating factors such as TGF-b1, IL-4,
and IL-10 [6,7].
In our previous studies we investigated the phenotype and
function of the CNS-resident macrophages, which are also
referred to as microglia. We found that microglia in the normal
CNS expressed a number of the M2 markers, including Fizz1,
Ym1, IL-10 and IL-4 [8]. It was recently demonstrated that
peritoneal, pleural, splenic, lung, liver and adipose tissue resident
macrophages also exhibit properties of the M2-like cells by
expressing several M2 markers including CD206, Fizz1 and Arg1
[6,9]. This indicates that tissue resident macrophages often exhibit
properties of M2 cells under normal physiological conditions;
however it is unclear how this phenotype is induced and
maintained.
Allergic airway and lung inflammation, a hallmark of bronchial
asthma, represents a complex pathological condition that is
characterized by bronchial hyper-responsiveness, airway eosino-
philia, and macrophage activation. It is known that IgE antibodies
recognizing a particular allergen contribute to the tissue inflam-
mation by triggering the release of the pro-inflammatory
substances from mast cells (e.g. histamine, prostaglandins)
culminating in the appearance and accumulation of pro-inflam-
matory, as well as Th2 cytokines IL-4 and IL-13 [10]. The
ovalbumin (OVA)-induced allergic lung inflammation is a widely
used mouse model of asthma that recapitulates the airway
eosinophilia, pulmonary inflammation and elevated levels of IgE
antibodies frequently found in patients with allergic bronchial
asthma [11].
MicroRNAs are a family of short (22–23 nucleotides) non-
coding RNAs that are involved in the epigenetic regulation of gene
expression by controlling the mRNA translation and/or turnover
[12]. MicroRNA function is crucial for many physiological
processes including cell proliferation, apoptosis and differentiation
[13]. It was recently demonstrated that miRNAs are also operative
in macrophage polarization [7,12,13]. For example, miR-155 and
miR-146a are associated with M1 phenotype and are up-regulated
by the M1-inducing stimuli such as IFN-c and LPS [7,12,13].
Recent study suggests that miR-223 contributes to the develop-
ment of the M2 phenotype in macrophages residing in the adipose
tissue [7,14]. We have previously demonstrated that in contrast to
the mouse macrophages in the periphery, microglia expressed high
levels of miR-124, but not miR-223 [15], and this microRNA
contributed to the M2 phenotype in these cells, suggesting the role
of miR-124 in polarization of CNS-resident macrophages [13,15].
However, it was not clear from our previous studies whether miR-
124 serves as a universal regulator of M2 macrophage polarization
or its function was restricted to the microglial cells in the CNS
only.
In this study we investigated how miR-124 contributes to the
phenotype of various tissue subsets of the M2 macrophages in vitro
and in vivo. We found that exposure to the Th2 cytokines IL-4 and
IL-13 but not the anti-inflammatory cytokines IL-10, TGF-b or
the M1-inducing stimuli, such as IFN-c/LPS, resulted in miR-124
expression in the bone marrow (BM) derived and peritoneal
macrophages, as well as in a macrophage cell line RAW 264.7.
The expression of miR-124 in the microglia did not require the IL-
4/IL-13 receptors and STAT6 signaling pathways, whereas in the
lung macrophages, miR-124 was expressed at a low level in an IL-
4/IL-13 dependent fashion and was substantially up-regulated
during the OVA-induced allergic lung inflammation. We also
found that miR-124 was essential for the up-regulation of CD206
and Ym1, and downregulation of CD86, iNOS (NO producing
enzyme) and TNF in the M2-polarized macrophages. Finally, we
demonstrated that the subset of human intermediate
CD14+CD16+ monocytes, which is associated with asthma
progression and allergic inflammation [16,17], expressed high
levels of miR-124. Thus, our study demonstrates that miR-124
contributes to the development of the M2 phenotype in various
types of monocytic cells of different origins and high level of
expression of this microRNA in lung macrophages is associated
with allergic lung inflammation.
Results
IL-4 and IL-13 Upregulate miR-124 in Macrophages on a
Transcriptional Level
We have previously found that transfection of macrophages
with miR-124 resulted in downregulation of the M1-associated
genes, such as TNF, MHC class II, and CD86, while at the same
time upegulating the M2-associated genes Fizz1, Arg1, and TGF-
b1 [15]. Thus, we hypothesized that miR-124 promotes the M2
polarization. To test our hypothesis we investigated factors that
upregulate miR-124 in macrophages and found that exposure to
IL-4 and IL-13 (M2a inducers) but not M1-inducing IFN-c and
LPS, or anti-inflammatory cytokines IL-10 or TGF-b1 (M2b
inducers) resulted in upregulation of miR-124 in the cultured BM-
derived and ex-vivo isolated peritoneal macrophages. Thus miR-
124 appears to be a marker of the M2a cells (Fig. 1A). The
observed effect of treatment with IL-4 or IL-13 was detected at a
wide range of IL-4 or IL-13 concentrations (10–200 ng/ml; not
shown) and was stronger for the BM-derived macrophages
resulting in a 6–12-fold upregulation of miR-124. However, there
were interexperimental variations, depending on the initial assay
conditions, in BM-derived macrophages cultured in the presence
of M-CSF. Statistical analysis of eight separate experiments for IL-
4 treated vs. untreated BM-derived macrophages is shown in
Fig. 1B. The effect of IL-4 or IL-13 on the ex-vivo isolated
peritoneal macrophages or the macrophage line RAW 264.7 was
less prominent, resulting in a 2–8-fold upregulation of miR-124,
but these results were more consistent in the experimental repeats
(Fig. 1C, E). Statistical analysis of six separate experiments for IL-
4 treated vs. untreated peritoneal macrophages is shown in
Fig. 1D. We explained the observed differences by the various
baseline ‘‘M0 states’’ of activation of BM-derived and peritoneal
macrophages. For example, the peritoneal macrophages from B6
mice at their M0 state expressed high levels of IL-4 when
compared to the BM-derived macrophages of the same mouse
strain or the ex-vivo isolated adult microglia, which was shown to be
of the M2 phenotype [8] (Fig. S1A). Thus, peritoneal macro-
phages already possess an M2-like phenotype and produce
endogenous IL-4 that may act as an autocrine factor; therefore
these cells may be less responsive to the exogenous IL-4 exposure.
In contrast to the ex-vivo isolated peritoneal macrophages, cultured
BM-derived macrophages from B6 mice expressed TNF at their
M0 state (Fig. S1B), demonstrating M1-like properties. The
spontaneous expression of TNF in the BM-derived macrophages
varied from one experiment to another influencing their respon-
siveness to IL-4 and the extent of the IL-4-induced M2
phenotypical markers (e.g. Fizz1, Arg1) and miR-124 expression
(not shown).
Since the induction of miR-124 in macrophages by IL-4 was
highly consistent in the peritoneal macrophages as well as the
macrophage cell line RAW 264.7, we further investigated the
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Figure 1. Analysis of miR-124 expression in macrophages polarized in vitro towards M1 (IFN-c/LPS), M2a (IL-4, or IL-13), or M2b
(TGF-b1, or IL-10). Bone marrow (BM) derived cultured macrophages (A, B), ex-vivo isolated CD11b+F4/80+ peritoneal macrophages (C, D), or
macrophage cell line RAW 264.7 (E) were incubated with media alone (Media), or IFN-c and LPS (IFN-c/LPS), or IL-4, or IL-13, or TGF-b1, or IL-10 for 24
hours, after which the expression of miR-124 was measured by the real-time RT-PCR as described in Materials and Methods. The data is representative
of eight (A, B), six (C, D) or five (E) separate experiments; mean6 S.E. of triplicate is shown in (A, C, E). Mean6 S.E. of eight separate experiments is
shown in (B) and mean 6 S.E. of six separate experiments is shown in (D) (**p,0.01).
doi:10.1371/journal.pone.0081774.g001
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kinetics and molecular mechanisms of miR-124 up-regulation by
IL-4 in the RAW 264.7 model system. This macrophage cell line
provided us with the desired level of reproducibility and sufficient
cell numbers needed for RNA isolation and analysis. We found
that miR-124 was upregulated as early as at 4 hours of RAW
264.7 incubation with IL-4 in cell culture (Fig. 1C). We further
investigated particular molecular mechanisms of how miR-124
was upregulated in the macrophages treated with IL-4. In theory
IL-4 could induce miR-124 on a transcriptional level or by
enhancing the processing of this miRNA as was shown previously
for other cell types [18,19]. If IL-4 induces miR-124 on the
transcriptional level, then longer precursor transcripts (pri-
miRNA) should be detected in the IL-4 treated macrophages.
Indeed, we found that IL-4 induced the expression of all three
known precursors for miR-124: pri-miR-124.1, pri-miR-124.2 and
pri-miR-124.3. The expression of pri-miR-124.3 was detected as
early as at 30 minutes (0.5 hour) after exposure of the
macrophages to IL-4 and was still observed 24 hours later. The
expression of two other transcripts, pri-miR-124.1 and pri-miR-
124.2, was transient and was detected less frequently between
experiments (Table 1). To conclude, we found that IL-4 is
capable of inducing the miR-124 expression in macrophages
in vitro on a transcription level.
Expression of miR-124 in Microglia is IL-4/IL-13-
independent
In the following experiments we investigated whether IL-4 or
IL-13 was required to induce the expression of miR-124 in
macrophages in vivo. We have previously shown that microglia in
the normal CNS exhibited properties of the M2-type macrophages
[8] and expressed high levels of miR-124 but not the M1
phenotype associated miR-155 or another reported M2-associated
miR-223 [15]. During the course of the Th1-mediated autoim-
mune inflammation (i.e., experimental autoimmune encephalitis)
the expression of miR-124 declined [15], while the CNS-derived
IL-4 was shown to be important for the induction of several M2
markers in the microglia [8]. Thus the CNS-derived IL-4 and IL-
13 could potentially induce miR-124 expression in the microglia of
the normal CNS. To investigate whether IL-4 and IL-13 induce
the expression of miR-124 in the CNS, we compared the levels of
miR-124 expression in the microglia isolated from the wild type
(WT), STAT6 (Signal transducer and activator of transcription 6
that is downstream of IL-4 and IL-13 receptors)-, or IL-4-, and IL-
4/IL-13 receptor common a-chain (IL-4/13R or IL-4Ra)-
deficient mice. We found that in the CNS of healthy STAT6-,
IL-4- and IL-4/13R-deficient mice microglia had typical non-
activated CD45lowMHC class II negative phenotype similar to that
of WT controls (not shown) and did not have decreased levels of
miR-124 when compared to the WT controls of the same strains
(Fig. S2). We have concluded that IL-4 and IL-13 did not
contribute to the expression of miR-124 in the microglia of the
CNS in vivo. In our previous experiments we demonstrated that co-
culture of macrophages with a neuronal line resulted in the up-
regulation of miR-124 [15]. Thus we proposed that certain
neuronal factors exist besides IL-4 or IL-13 that have an ability to
upregulate the miR-124 expression in the microglia of the CNS
[13]. Thus, miR-124 expression in the CNS-resident microglia is
IL-4/IL-13 independent.
Expression of miR-124 in Normal Lung Resident
Macrophages is IL-4/IL-13-dependent
Since we found that IL-4 or IL-13 did not induce miR-124 in
the microglia of the CNS (Fig. S2), we investigated the expression
of miR-124 under the influence of IL-4 or IL-13 in the resident
macrophages of other tissues such as lungs. We selected lung
macrophages since they exhibit an M2 phenotype similarly to
testicular macrophages [20], and the lung is the organ harboring
the allergic inflammation in human pathologies such as asthma,
mediated by IL-4 and IL-13 [11,17]. Although the expression of
miR-124 in the lung resident (interstitial) macrophages was lower
than in the microglia, it was still detected in WT B6 mice.
Expression of miR-124 in IL-4 deficient (or in IL-4/13R deficient
mice; not shown) was 2–4 fold lower compared to WT mice
(Fig. 2A). We hypothesized that endogenous IL-4 contributed to
the miR-124 expression in the lung resident macrophages under
baseline conditions. To confirm this, we injected intravenously IL-
4 into IL-4 deficient mice that lack endogenous IL-4, and
registered a 2.7-fold upregulation of miR-124 in the lung tissue
macrophages which reached the level comparable to WT mice
with endogenous IL-4 (Fig. 2A). This finding suggests that
endogenous IL-4 mediates miR-124 expression in the lung
macrophages in vivo.
Expression of miR-124 is Substantially Upregulated in the
Lung Macrophages during an Allergic Inflammation
To investigate the miR-124 dynamics during inflammation, we
used the mouse asthma model, also known as ‘‘OVA-induced
allergic lung inflammation’’. It was demonstrated that similar to
human asthma, this experimental disease is mediated by IL-4 and
IL-13 cytokines [11]. We compared the level of the miR-124
expression in the alveolar macrophages sorted by FACS from the
BAL cells of WT vs. IL-4/13R deficient mice with the OVA-
induced allergic lung inflammation. As shown in Fig. 2B, the
expression of miR-124 in alveolar macrophages was upregulated
Table 1. Analysis of kinetics of expression of the miRNA-124
precursor transcripts pri-miRNA-124.1, pri-miRNA-124.2 and
pri-miRNA-124.3 in RAW264.7 cells treated with IL-41.
Treated with IL-4
Experiment
# pri-miRNA Untreated 0.5 h 4 h 24 h
1 Pri-miR-124-1 22 2 +3 2
Pri-miR-124-2 2 2 + 2
Pri-miR-124-3 2 + + 2
2 Pri-miR-124-1 2 2 2 2
Pri-miR-124-2 2 2 2 2
Pri-miR-124-3 2 + + +
3 Pri-miR-124-1 2 + + 2
Pri-miR-124-2 2 2 2 2
Pri-miR-124-3 2 + + +
4 Pri-miR-124-1 2 2 + 2
Pri-miR-124-2 2 2 + 2
Pri-miR-124-3 2 2 + 2
1The cells were treated with 50 ng/ml of IL-4 and harvested at indicated time
points after adding of IL-4. RNA was isolated and expression of pri-miR-124.1,
pri-miR-124.2 or pri-miR-124.3 was analyzed by real-time RT PCR as described in
Materials and Methods. Data of four experiments performed in triplicates for
each precursor is shown.
2Expression was considered negative (‘‘2’’) if no product was detected after
more than 40 cycles of amplification.
3Expression was considered positive (‘‘+’’) for CT,35 cycles.
doi:10.1371/journal.pone.0081774.t001
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in WT but not in IL-4/13R deficient mice during the course of the
allergic inflammation. It was previously demonstrated that the IL-
4/13R deficient mice are resistant to the OVA-induced lung
inflammation [21], consistent with the fact that in our experiments
the level of the miR-124 expression in the macrophages of IL-4/
13R deficient mice challenged with OVA was even lower than in
healthy mice (Fig. 2B; Healthy WT mice). Finally we found that
miR-124 was expressed at a high level during the allergic
inflammation in the lung interstitial macrophages when compared
to healthy mice of B6 and BALB/c strains (Fig. 2C). The presence
of miR-124 was barely detectable in the lung resident (interstitial)
macrophages from the IL-4/13R deficient mice during the allergic
inflammation and was reduced 5-fold in IL-4 deficient mice when
compared to WT controls of the same strains (Fig. 2C). Thus the
expression of miR-124 is highly upregulated in the IL-4/IL-13
Figure 2. Analysis of the miR-124 expression in lung macrophages in the baseline conditions or during the OVA-induced allergic
lung inflammation. (A) Lung interstitial macrophages were isolated from the unmanipulated B6-WT mice, B6-IL-4 deficient mice, or B6-IL-4
deficient mice in which IL-4c was systemically administered as described in Materials and Methods and the expression of miR-124 was measured as in
Fig. 1. (B) Lung alveolar macrophages were isolated from the unmanipulated BALB/c-WT healthy mice, or BALB/c-WT and BALB/c-IL-4/13R deficient
mice with OVA-induced allergic lung inflammation and the expression of miR-124 was analyzed. (C) Lung interstitial macrophages were isolated from
healthy B6-WT and healthy BALB/c-WT vs. B6-WT and B6-IL-4 deficient mice, or BALB/c-WT and BALB/c-IL-4/13R deficient mice with an OVA-induced
allergic lung inflammation and expression of miR-124 was analyzed. In (A–C), Mean 6 S.E. of 4–6 individual animals is shown (*, p,0.05; **, p,0.01;
***, p,0.005).
doi:10.1371/journal.pone.0081774.g002
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dependent manner in the lung macrophages during the allergic
inflammation.
M1 Macrophages are Resistant to Induction of M2
Phenotype and Expression of miR-124
We next investigated whether miR-124 could be induced by IL-
4 in M1 macrophages and whether M1 macrophages could be
converted into M2 in miR-124 dependent manner. To test this we
polarized macrophages towards M1 for 24 hours, washed them by
changing media several times, and then incubated cells with IL-4
for next 24 hours. Unpolarized (M0), M1, and M2 polarized
macrophages were used as a proper reference controls. We found
that M1 macrophages treated with IL-4 neither downregulate M1
markers nor upregulate M2 markers and exhibited
CD206lowMHC class IIhiCD86hi phenotype (Fig. 3A, M1RM2)
that resembled M1 (Fig. 3A, M1). On the other hand M2
macrophages upregulated CD206 and had low level of CD86
when compared to M0 (Fig. 3A, M0). M2 macrophages exhibited
typical CD206hiMHC class IIintCD86lo phenotype (Fig. 3A, M2).
In addition, M1-specific miR-155 was highly upregulated in M1
macrophages (Fig. 3B, M1) and stayed at a very high level in M1
macrophages treated with IL-4 (Fig. 3B, M1/M2) when
compared to M0 and M2 macrophages that expressed very low
levels of miR-155 (Fig. 3B,M0 and M2). We also found that miR-
124 was upregulated in M2 macrophages but was not induced in
M1RM2 cells (Fig. 3C, M1/M2). Thus treatment of M1
macrophages with IL-4 did not result in either upregulation of
miR-124 or conversion of M1 cells into M2 as determined by
expression of phenotypical markers.
miR-124 Contributes to the Upregulation of CD206 and
Ym-1 and Downregulation of CD86, iNOS, and TNF in M2
Polarized Macrophages
We further investigated whether miR-124 expression contrib-
uted to the expression of the M2 markers in the polarized
macrophages. As we mentioned earlier, overexpression of miR-
124 resulted in downregulation of the M1 markers (MHC class II
and CD86) and up-regulation of the M2 markers (TGF-b1, Fizz1
and Arg1) [15]. Here we investigated, whether a knockdown of
miR-124 in macrophages treated with IL-4 would result in a
change of their M2-indiced phenotype. As it was established
earlier by other investigators and confirmed by our previous
studies, the treatment of macrophages with IL-4 upregulated M2
markers including TGF-b1, Fizz1, Ym1, Arg1, CD206 and
downregulated several M1 markers such as iNOS and TNF [8].
In addition to that, we found that the treatment with IL-4
upregulated miR-124, while treatment with IFN-c/LPS upregu-
lated miR-155 (Fig. 3B,C).
To test the role of miR-124 in induction and maintenance of
M2 phenotype, we performed the M2 polarization of the
peritoneal macrophages by IL-4 in the presence of a miR-124
inhibitor (anatagomir) or control scrambled antagomir. We found
that in IL-4 treated macrophages miR-124 inhibitor decreased
expression of M2 markers CD206 and Ym-1 and increased
expression of M1 markers CD86, iNOS, TNF and miR-155 when
compared to control (Fig. 4A–C). The miR-124 inhibitor had a
little or no effect on the expression of MHC class II (Fig. 4A),
TGF-b1 and Fizz1 (Fig. 4C) in the IL-4 treated macrophages.
Surprisingly, the expressions of M2 markers Arg1 and IL-10 were
even enhanced in the presence of the miR-124 inhibitor (Fig. 4C),
probably due to the compensatory redundant mechanisms of
regulation of Arg1 and IL-10 expressions by IL-4. Thus miR-124
contributes to the M2 phenotype acquisition by affecting the
expression of multiple markers such as CD206, Ym-1, iNOS, TNF
and CD86.
Human Intermediate CD14+CD16+ Monocytes Express
High Levels of miR-124 and Exhibit Properties of M2-like
Cells
It was reported that human monocytic cells are altered in the
peripheral blood of patients with allergies and severe asthma
leading to a selective expansion of intermediate CD14+CD16+
subset [16,17]. We further investigated the expression of miR-124
in human peripheral blood monocytes and found that in contrast
to their mouse counterparts that expressed rather low amounts of
miR-124 [15], human circulating monocytes exhibited high levels
of miR-124 (not shown). We then asked which subset of human
monocytes expressed miR-124 and found that classical
CD14++CD162 monocytes had intermediate levels of miR-124,
CD14+CD16+ monocytes contained the highest levels of miR-124,
and non-classical CD14lowCD16+ were virtually miR-124-negative
compared to that of CD4 T cells used as a negative control
(Fig. 5A). Since it was reported that the expression of miR-155
contributed to the phenotype of M1 cells [13] (Fig. 3B), we
investigated the expression of this microRNA in the aforemen-
tioned three subsets of human monocytes. The classical
Figure 3. Treatment of M1 macrophages with IL-4 did not
result in upregulation of miR-124 and conversion of M1 cells
into M2. Peritoneal CD11b+F4/80+ macrophages were isolated and left
unpolarized (M0) or polarized towards M1, or M2, or first polarized
towards M1, and after 24 hours, washed and polarized towards M2
(M1RM2 or M/M2) as described in Materials and Methods. After which,
the cells were stained for CD206, CD86 and MHC class II and analyzed
by FACS (A), or used for RNA isolation and analysis of expression of miR-
155 (B) or miR-124 (C) by real-time RT-PCR. One representative
experiment of three is shown in (A–C); mean 6 S.E. of triplicate is
shown in (B, C).
doi:10.1371/journal.pone.0081774.g003
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CD14++CD162 monocytes expressed the highest levels of miR-
155. On the other hand, CD14+CD16+ intermediate monocytes
expressed miR-155 only at a background level found in CD4 T
cells. Finally, non-classical CD14lowCD16+ monocytes also
expressed miR-155 (Fig. 5B). Thus, classical monocytes demon-
strated the properties of dually activated M1/M2-like cells,
intermediate CD14+CD16+ monocytes exhibited the properties
of M2-like cells, and non-classical CD14lowCD16+ monocytes
those of the M1-like cells. We also used the expression of miR-424,
that determines early stages of differentiation of (immature)
Figure 4. miR-124 inhibitor decreased expression of M2 markers CD206 and Ym-1 and increased expression of M1 markers CD86,
iNOS, TNF, and miR-155 in the in-vitro polarized M2 macrophages. Peritoneal CD11b+F4/80+ macrophages were isolated and treated with IL-
4 in the presence of liposomes with miR-124 inhibitor or control antagomir for 24 hours as described in Materials and Methods. After which, viable
cells were separated using Ficoll gradient and either stained for CD206, CD86 and MHC class II and analyzed by FACS (A, B), or used for mRNA
isolation and analysis of expression of mRNA transcripts for TGF-b1, IL-10, Fizz1, Ym1, Arg1, iNOS, TNF, and miR-155 (C). In (A), the red line represents
staining for isotype-matched control and the blue line - staining for surface markers. Each histogram shows overlay images. The percentage of
positive cells is shown on each histogram in the upper right corner and the mean fluorescence intensity (MFI) - in the bottom right corner. The mean
MFI 6 S.E. of three separate experiments is shown in (B) (*, p,0.05) and mean 6 S.E. of a triplicate is shown in (C).
doi:10.1371/journal.pone.0081774.g004
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monocytic cells [22], as a an additional control microRNA, and
found that in contrast to two other subsets of CD16+ monocytes,
classical CD14++CD162 monocytes had high levels of the miR-
424 expression. Intermediate CD14+CD16+ monocytes showed
low levels of miR-424 expression and non-classical macrophages
were miR-424-negative (Fig. 5C). Our data is in good agreement
with previous studies by others indicating that classical monocytes
represent a less mature population and classical and intermediate
subsets are related to each other closer than to non-classical
monocytes [23]. We now show that classical and intermediate
subsets expressed miR-124 and miR-424 while non-classical
monocytes did not, suggesting that intermediate CD14+CD16+
monocytes exhibited a more mature phenotype and properties of
the M2-like cells.
Discussion
We have shown previously that miR-124 determines the
phenotype of the resident macrophages (microglia) in the CNS
that exhibited properties of the M2 macrophages [8,15]. In this
study we demonstrate that miR-124 contributes to the M2
phenotype of monocytic cells of various origins from several
anatomic locations. We found that miR-124 is upregulated in
macrophages either through an IL-4/IL-13-dependent pathway
during an allergic inflammation in the lung or independent of the
IL-4/IL-13 pathway in case of the microglia.
Recent findings provided evidence that in addition to the
microglia, resident macrophages in many tissues exhibit properties
of the M2 cells in their default state (reviewed by Mills [6]). Our
previous study established that miR-124 directly targeted CEBPa,
a master transcription factor of differentiation of monocytic cells
[13,15]. We showed that miR-124 dowregulated CEBPa in
microglia and macrophages resulting in the acquisition of the M2-
like phenotype [15]. It was recently shown that Trib1, a molecule
involved in lipid metabolism, was also required to support the M2-
like phenotype (the expression of CD206, Arg1 and Fizz1) of
resident macrophages in bone marrow, spleen, lungs and adipose
tissue [9]. Trib1 is involved in the regulation of protein
degradation by interacting with the E3 ubiquitin ligase. Interest-
ingly, the level of CEBPa expression in Trib1 deficient mice was
elevated due to the impaired degradation of this transcription
factor resulting in the loss of the M2 phenotype of resident
macrophages [9]. In line with our previous findings [15], the
authors demonstrated that increased expression of CEBPa
correlated with the loss of the M2 phenotype [9]. Thus we believe
that at least in the case of resident macrophages, the downreg-
ulation of CEBPa by miR-124 or by other means (e.g. CEBPa
degradation regulated by Trib1) results in skewing towards the
M2-like phenotype. Metabolic changes in the adipose tissue [9,24]
or autoimmune inflammation in the CNS both resulted in a shift
of balance from the M2 phenotype towards the M1 phenotype in
resident macrophages [8,15]. In the current study we show that
during the allergic inflammation in the lung the balance is shifted
towards the M2 phenotype, resulting in the upregulation of miR-
124.
It was demonstrated that IL-4 is important for the expansion of
resident macrophages and the maintenance of their M2 phenotype
in vivo [3]. We found that miR-124 contributed to the development
of this phenotype resulting in the upregulation of CD206 and
downregulation of CD86. As demonstrated in the studies utilizing
the Trib1-deficient mice, increased expression of CEBPa resulted
in the dowregulation of CD206 [9], while we previously showed
that a decrease in CEBPa expression resulted in the downregu-
lation of CD86 [15]. Since we postulated that miR-124 targeted
CEBPa [15], we hypothesized that miR-124 contributed to the
upregulation of CD206 and downregulation of CD86 in IL-4
treated macrophages by targeting CEBPa. We were able to link
the CEBPa-PU.1 pathway was to the regulation of the CD86
expression [15]. However both from our study and the study by
Satoh et al. [9] it is not yet clear, how the downregulation of
CEBPa leads to the upregulation of CD206. Future experiments
will determine the particular mechanisms of regulation of CD206
expression by miR-124 and CEBPa. One of the possible
alternative mechanisms of skewing macrophages towards the M2
phenotype is by the induction of the miR-124 expression utilizing
the ability of miR-124 to target IL-6R and inhibit the IL-6R-
STAT3 pathway, which is associated with the development of the
M1 phenotype [25]. As for miR-124 it was also shown that
another M2-associated microRNA, miR-223, was capable of
inhibiting the STAT3 pathway [26]. Interestingly, in contrast to
our previous studies when overexpression of miR-124 led to the
upregulation of mRNA for TGF-b1, Fizz1 and Arg1 [15], the
inhibition of miR-124 in IL-4-treated macrophages of the current
study did not result in the dowregulation of expression of
transcripts for TGF-b1, IL-10, Fizz1 and Arg1. We envision two
possible explanations for this phenomenon. First, the miRNA
inhibitors may not work efficiently enough to completely
counteract the function of miR-124 in the cells. Second, there
exist other redundant molecular mechanisms involved in the
regulation of these markers. We favor the second possibility, since
we found that the expression of Arg1 was elevated even further in
the presence of the miR-124 inhibitor. One of the possible
candidates that may cause the upregulation of Arg1 is miR-223,
which is expressed in macrophages in the periphery but not in the
CNS [15]. It was recently demonstrated that miR-223 is up-
regulated by IL-4 resulting in the upregulation of Arg1 [14]. Given
the fact that miR-124 negatively regulates the expression of miR-
223 as shown by us previously [15], there is a possibility that
inhibition of miR-124 in the IL-4 treated macrophages results in a
further upregulation of miR-223 and further increase in the Arg1
expression. Thus there is a possibility that miR-223 can substitute
for miR-124 in macrophages treated with miR-124 inhibitor.
Finally, besides miR-124 and miR-223, other microRNAs may
also contribute to M2 phenotype of macrophages further
suggesting redundant mechanisms in the regulation of M2
polarization by several microRNAs [27].
Thus overexpression of miR-124 resulted in downregulation of
M1 genes (CD86, TNF, iNOS) and upregulation of M2 genes
(Fizz1, TGF-b1, Arg1) as we previously reported [15]. Therefore
miR-124 overexpression could replace IL-4 in order to induce
expression of M2 related genes and downregulate expression M1
related genes. In this study, we demonstrated that miR-124 is
induced by IL-4 and inhibition of miR-124 in IL-4 treated
macrophages resulted in downregulation of several M2 genes
(CD206, Ym-1) and upregulation of M1 genes (CD86, iNOS,
TNF, miR-155). However expression of Fizz1 and TGF-b1 were
not changed and expressions of Arg1 and IL-10 were even
enhanced by miR-124 inhibitor, suggesting that there are other
mediators for M2 activation besides miR-124. Thus miR-124
could only partially substitute for IL-4 in knockdown experiments.
Also, in vitro macrophages often exhibit the properties of M1 or
M2-like cells depending on the cell culture conditions. Many
factors were reported to contribute to the M2-like phenotype
including fetal bovine serum (FBS), M-CSF, apoptotic bodies, etc.
On the other hand, GM-CSF, cell debris or serum-free media
often induce the M1-like phenotype [6]. We found that BM-
derived macrophages from B6 mice even in the media with FBS
often exhibited the M1-like properties as determined by the MHC
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Figure 5. Analysis of expression of miR-124 (the M2 marker), miR-155 (the M1 marker) and miR-424 (the marker for immature
monocytes) in the populations of classical (CD14++CD162), intermediate (CD14+CD16+) and non-classical (CD14lowCD16+) human
monocytes. (A) Mononuclear cells were isolated from the peripheral blood of healthy individuals and stained for CD14, CD16 and CD4. The
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class II, CD86, and TNF expression [15]. Therefore, in-vitro
experiments aiming at inducing the clearly defined M1 or M2
phenotype could be rather difficult to perform due to a high
variability. We also found that induction of miR-124 in cultured
bone-marrow derived macrophages depended highly on their
initial state of activation and the baseline levels of expression of
TNF. On the other hand, ex-vivo isolated peritoneal macrophages
were already of the M2-like phenotype, given they were producing
IL-4 (Fig. S1A) and were able to up-regulate miR-124 in response
to the exogenous IL-4 up to 2–8 fold (Fig. 1). However, our in vivo
results demonstrate the very dramatic (11-fold) upregulation of
miR-124 during an allergic inflammation, indicating a role for
miR-124 in alternative macrophage activation in vivo (Fig. 2).
Allergy is a rather common disease of the modern world, which
is likely to be connected to the shift of the M1/M2 polarization
balance in the lung macrophages (reviewed by Mills [6] ). It was
demonstrated that allergic inflammation is associated with the M2
activation of macrophages in vivo [28,29]. The importance for IL-4
and IL-13 for the development of allergic inflammation was clearly
demonstrated in mouse models using IL-4 and IL-4/13R deficient
mice [21,30]. Moreover, IL-4/13R-STAT6 signaling pathway was
essential for both the induction of M2 phenotype in the lung
macrophages and the development of an allergic lung inflamma-
tion [21]. Several microRNAs were recently shown to become
upregulated during an allergic lung inflammation. miR-146 and
miR-21, which are involved in the macrophage activation and the
resolution of inflammation, respectively [13], were shown to be
associated with allergic responses [31,32], so as was miR-223
which was recently shown to contribute to the M2 phenotype
acquisition [14]. However, miR-223 is prominently expressed in
granulocytes and is not fully M2-specific [33]. Our study clearly
demonstrates that miR-124 may be used as an macrophage-
specific M2 marker, which is significantly upregulated in
macrophages during an allergic inflammation in mouse model.
In addition to the expression of miR-124 in lung macrophages
during an allergic lung inflammation, miR-124 could potentially
serve as a marker for changes of M1/M2 balance in the periphery.
We found that human monocytes from the peripheral blood of
healthy individuals expressed miR-124 with the highest level of
expression in the subset of the intermediate CD14+CD16+
monocytes. It was reported that this intermediate CD14+CD16+
subset (same subset is also referred to as CD14++CD16+ or
CD14highCD16+) was expanded in patients with allergies [16] and
asthma [17] and expressed a number of M2 surface markers such
as CD163, CX3CR1, IL-4R, TGF-b1 and IL-10 [17,34–36]. The
classical CD14+CD162 monocytes (or same subset of
CD14++CD162 or CD14highCD162 cells as described in other
publications) expressed both miR-124 and miR-155 (miR-155 is
associated with the M1 phenotype of the pro-inflammatory
macrophages in pathology [13]) and exhibited the properties of
dually activated M1/M2-lke cells (Fig. 5) [23,37] similarly to the
macrophages that migrated into the CNS from the periphery in
mice with neuroinflammation [8]. The non-classical
CD14lowCD16+ subset (also referred to as CD14+CD16++ or
CD14dimCD16+ in other publications) exhibited the properties of
the M1-like cells by expressing miR-155, TNF, IL-6, ROS, TLR4
and high levels of CCR2 [23,35,38,39]. The expression profile of
the M1 and M2-specific markers as well as the miRNA expression
patterns in these three subsets of human monocytes are
summarized in Table 2.
At the baseline, intermediate CD14+CD16+ (also referred to as
CD14++CD16+) subset expressed the highest level of transcripts for
TGF-b1 when compared to other two monocyte subsets [36]. This
confirms our observation that intermediate CD14+CD16+ cells
have M2-like phenotype. On the other hand, unstimulated non-
classical CD14lowCD16+ cells were potent stimulators of T cells
when compared to other two subsets of intermediate and classical
monocytes. This suggests that non-classical monocytes exhibit M1-
like phenotype [35], which confirm our observation in Fig. 5.
Upon LPS stimulation, intermediate CD14+CD16+ cells were the
only population that produce IL-10, whereas non-classical
CD14lowCD16+ were the main producers of TNF [35]. These
data also confirmed our observation shown in Fig. 5 that
CD14+CD16+ cells have M2-like phenotype, whereas
CD14lowCD16+ cells have properties of M1 cells. Recently it
was reported that in patients with multiple sclerosis (MS), an
autoimmune disease associated with Th1 autoimmune cells and
shifting balance towards M1, the expression of miR-124 was
downregulated and expression of miR-155 was upregulated in
whole monocyte population [40]. Thus upregulation of miR-155
and downregulation of miR-124 could represent expansion of
non-classical monocytes during autoimmune diseases such as MS
(Table 2).
The miRNA expression data we obtained, combined with the
phenotypical markers gives us a rather interesting perspective since
CD14lowCD16+ non-classical monocytes are expanding during
inflammation, infection and autoimmunity, whereas the functions
of the intermediate CD14+CD16+ monocytes are not well known
and these cells could hypothetically contribute to allergy [38,41].
The classical monocytes were reported to be less mature [36], but
our findings demonstrate that they also exhibit a dually activated
M1/M2 phenotype (Table 2). Thus miR-124 in monocytic cells
appears to be a useful marker for the M2-like macrophages and
the overexpression or inhibition of miR-124 in macrophages may
be beneficial for future therapeutic approaches to alter the balance
towards M2 or M1.
Materials and Methods
Mice
B6 (C57BL/6), BALB/c, IL-4 (B6-Il4tm1Nnt/J), IL-4/13R
(BALB/c-Il4ratm1Sz/J) and STAT6 (B6-Stat6tm1Gru/J) deficient
mice were purchased from Jackson Laboratories (Bar Harbor,
ME). Animals were housed in the Harvard Institutes of Medicine
specific pathogen free animal facility. All animal protocols were
approved by the Harvard Medical School Institutional Animal
Care and Use Committee and Chinese University of Hong Kong
Animal Ethics Committee. For experiments that involved pain and
distress the appropriate anesthetic and analgesic drugs were used.
Euthanasia was performed by using carbon dioxide.
Antibodies and Reagents
The fluorochrome-conjugated or biotinylated antibodies for
mouse CD11b, F4/80, MHC class II, CD86, and CD206 were
purchased from BD Biosciences, eBioscience, and Biolegend (all
form San Diego, CA). Anti-IL-4 antibodies and cytokines IFN-c,
populations of CD14++CD162, CD14+CD16+, and CD14lowCD16+ monocytes and CD14-CD16-CD4+ CD4 subsets were sorted by FACS and the
expression of miR-124, miR-155, and miR-424 was analyzed as described inMaterials and Methods. The mean MFI6 S.E. of three separate experiments
with three healthy individuals is shown. Expression of miR-124 (B), miR-155 (C) and miR-424 (D) was analyzed in three sorted monocyte populations
and compared to CD4 T cells. The level of expression of indicated miRNAs in CD4 T cells was used as a reference value.
doi:10.1371/journal.pone.0081774.g005
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IL-4, IL-13, TGF-b1 and IL-10 were purchased from R&D
Systems (Minneapolis, MN). The fluorochrome-conjugated anti-
bodies for human CD4, CD14 and CD16 were purchased from
BD Biosciences (San Diego, CA). miR-124 antagomir inhibitor or
control scrambled antagomir were purchased from Exiqon Inc
(Woburn, MA). LPS, chicken ovalbumin (OVA), and alum
adjuvant were purchased from Sigma (St. Louis, MO). For all
experiments, OVA protein was depleted of endotoxin (LPS) using
Affinity-PakTM Detoxi-GelTM columns (Pierce Biotechnology,
Rockford, IL) according to the manufacturer’s instructions. IL-4
complexes (IL-4c) were prepared by mixing IL-4 and anti-IL-4
antibodies and injected i.p. daily for 3 days as described previously
[3].
OVA-induced Allergic Inflammation
BALB/c and BALB/c-IL4/13R KO, or B6 and B6-IL4 KO
mice were injected i.p. three times weekly with OVA combined
with the adjuvant for the sensitization and then challenged
intranasally with the OVA solution similarly as described [29]. For
the sensitization, 20 mg of OVA were adsorbed onto 2.25 mg of
alum adjuvant (Pierce Biotech, Rockford, IL) by mixing for one
hour at room temperature in a total volume of 200 ml endotoxin-
free PBS (Sigma). One week after the last sensitization, OVA
challenge was initiated by instilling 25 mg OVA in 25 ml
endotoxin-free PBS into each nostril daily for five consecutive
days. During all experimental procedures, mice were anesthetized
by 2.5% isoflurane (Baxter Healthcare, Deerfield, IL) in a closed
chamber using a VetEquip Inhalation Anesthesia System
(Pleasanton, CA). For experiments, mice were sacrificed 24 hours
after the last challenge.
Cell Lines
RAW 264.7 cell line was purchased from ATCC (Manassas,
VA) and maintained in DMEM media supplemented with 5%
FBS. RAW264.7 cells were incubated with IL-4 at a range of
concentrations (10–200 ng/ml) for 0.5, 4 and 24 hours.
Bronchoalveolar Lavage (BAL)
The lungs of sacrificed animals were lavaged by cannulating the
trachea and gently injecting/recovering (5X) of 0.8 ml of a pre-
warmed (37uC) lavage fluid (PBS w/o Mg+2 and Ca+2). The BAL
fluid was combined in an ice-cold 15 ml Falcon tube containing
100 ml of FBS (Invitrogen, Carlsbad, CA), and then passed
through a 70 mm nylon cell strainer filter (BD Biosciences) to
remove cell debris. Filtered BAL fluid was centrifuged at 300 g,
4uC for 10 minutes and the resulting cell pellet was washed twice
using 0.5 ml of PBS and then re-suspended in 0.5 ml of FACS
buffer (HBSS with 10 mM HEPES, pH 7.4, 2% FBS).
Cell Isolation and Culture
For bone marrow (BM)-derived macrophages, BM was isolated
from the 4–6 weeks old B6 mice; after erythrocyte lysis,
mononuclear cells were incubated with M-CSF (10 ng/ml) in
DMEM media (ATCC) supplemented with 10% FBS for 5 days as
described [15]. The medium was changed every 3 days. Peritoneal
macrophages were isolated from unmanipulated B6 mice by
means of a peritoneal lavage with PBS as described earlier [15,20]
and magnetic beads-sorted population of F4/80+CD11b+ cells was
used for polarization towards the M1 or M2 phenotype. For the
M1 or M2 polarization, ex-vivo isolated and pre-sorted peritoneal
or cultured BM-derived macrophages were incubated with IFN-c
(200 ng/ml) and LPS (200 ng/ml); or IL-4 (50–100 ng/ml), or IL-
13 (50–100 ng/ml), or TGF-b1 (100–200 ng/ml), or IL-10 (100–
200 ng/ml) for 24 hours accordingly, as described earlier [8,20].
For the isolation of microglia from the normal CNS, mice were
perfused intracardially with PBS prior to the dissection of the brain
and spinal cord, which were then homogenized; mononuclear cells
were isolated from the homogenates using 40%/70% Percoll
gradients. FACS analysis demonstrated a 94–96% purity of the
CD11b+CD45low microglial cells in the preparation of the CNS
mononuclear cells as was described previously in our studies
[8,42,43].
For the isolation of alveolar macrophages, BAL cells from each
mouse were sorted by FACS using FSC/SSC/FL-1 gating
strategy, which is based on the selection of cells with an increased
Table 2. Overview of the M1 and M2 phenotypic markers and microRNA expression in the populations of classical (CD14++CD162),










Proposed type of activation/
polarization
M1/M2-like M2-like M1-like
Maturation Immature Mature Very mature
MicroRNA expression miR-155; miR-124 (intermediate);
miR-424 (high)
miR-124 (high); miR-424 (low) miR-155
M1 Markers miR-155; MHC class II (low); CD86
(low); CCR2 (intermediate)
MHC class II; CD86 (intermediate);
CCR2 (low)
miR-155; MHC class II; CD86 (high); CCR2
(high); TLR4; TNF; ROS; Stimulation of T
cells
M2 Markers miR-124 (intermediate); CD163
(intermediate); IL-10
miR-124 (high); CD163 (high);




GM-CSF administration Allergy, Asthma Inflammation, Infection, Autoimmunity:
TB2; HIV; SIV; Sepsis; Atherosclerosis; RA;
T1D; IBD; MS(?)
1See explanations and references in the text.
2Abbrevations: TB, tuberculosis; HIV, human immunodeficiency virus; MS, multiple sclerosis SIV, simian immunodeficiency virus; RA, rheumatoid arthritis; T1D, type 1
diabetis; IBD, inflammatory bowel disease.
doi:10.1371/journal.pone.0081774.t002
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size, medium granularity and high autofluorescence that corre-
spond to the population of alveolar macrophages [29].
For the isolation of lung resident (interstitial) macrophages,
lungs after BAL were digested for one hour at 37uC with a
Collagenase and DNase mix solution (Sigma). The digested
material was than filtered through a 70 mm nylon mesh cell
strainer (BD Falcon) to prepare cell suspensions and lung
macrophages were sorted by using anti-mouse CD11b magnetic
beads (Miltenyi Biotech Inc.) according to instructions provided by
the kit.
In all our conditions for various mouse strains, we isolated
sufficient amount of macrophages from lungs: 0.5–0.96106/
mouse for alveolar macrophages and 1–36106/mouse for
interstitial macrophages to perform analysis of miR-124 expression
by real-time RT-PCR.
Human mononuclear cells from peripheral blood of healthy
individuals were isolated by Ficoll-Hypaque Density Media
(Sigma) and the cells were stained for CD4, CD14 and CD16 in
FACS buffer after blocking with FcR blocking antibodies (BD
Biosciences) and the population of mononuclear cells was
determined using the FSC/SSC mononuclear gate for the analysis
of the CD14, CD16 and CD4 surface markers expression. Use of
normal human peripheral blood mononuclear cells from anony-
mous healthy individuals for in vitro experiments was approved by
the institutional review boards of the Brigham and Women’s
Hospital and all healthy subjects provided written informed
consent prior to enrollment into study. The data from human
blood samples was obtained and analyzed without records of any
personal information to ensure complete anonymity.
In all experiments, isolated and sorted cells were immediately
centrifuged at 300 g for 10 minutes at 4uC, the supernatant was
carefully decanted, the cell pellet was snap frozen on dry ice and
stored at 280uC for the subsequent RNA isolation and miRNA
expression analysis [44].
Transfection of Macrophages with miR-124 Inhibitor
The miR-124 inhibitor (LNA-containing antisense oligonucle-
otide) or control scrambled antagomir (both from Exiqon) were
used for in vitro transfections of the peritoneal macrophages
cultured in the presence of IL-4 for 24 h. For transfection, miR-
124 inhibitor was complexed with Lipofectamin 2000TM (Invitro-
gen) as described previously [15,45].
Flow Cytometry and Cell Sorting
The 1–3–color flow cytometry analysis was conducted in the
Flow Cytometry sorting core facility following standard proce-
dures. Staining of the cells for their surface markers was performed
after the FcR blocking (BD Biosciences) in FACS buffer on ice for
20 minutes as described earlier [44]. The Flow cytometry analysis
was conducted on the LSR II and LSR-Fortessa Cytometers, and
the cell sorting was performed on the FACSAria Cytometer (all
from BD Biosciences). Sorting purities were 98–100% as
determined on the FACSAria sorter by reanalyzing the sorted
populations [44].
Analysis of miRNA and pri-miRNA Expression
For the analysis of miR-124, miR-155, and miR-424 expression
in the populations of monocytic cells, total RNA was isolated using
miRNeasy Mini Kit (Qiagen), and real-time RT-PCR analyses
were carried out using the TaqMan miRNA assays and the proper
mouse and human primer and probe sets (Applied Biosystems).
The relative expression was calculated by using the DCT method
and normalized to the uniformly expressed snoRNA55 (Applied
Biosystems) as described earlier [44]. For analysis of miRNA
expression, we first normalized our data to housekeeping short
non-coding RNA snoRNA55 and then normalized to reference
sample (defined as 1.0). In all our experiments snoR55 was
detectable after 20–25 cycles of amplification. Pri-miR124.1, pri-
miR-124.2 and pri-miR-124.3 were analyzed using the
mm03307218 (pri-mmu-124-1), mm03307226 (pri-mmu-124-2),
and mm03306225 (pri-mmu-124-3) primers from Life Technolo-
gies. All qRT-PCRs were performed in triplicates, and the data
are presented as mean 6 standard deviations (S.D.) or standard
errors (S.E.).
Analysis of mRNA Expression
For the analysis of the mRNA expression for TGF-b1 (forward
primer, 59-CAGAGCTGCGCTTGCAGAG; reverse primer, 59-
GTCAGCAGCCGGTTACCAAG); Arg1 (forward primer, 59-
CTTGGCTTGCTTCGGAACTC; reverse primer, 59- GGA-
GAAGGCGTTTGCTTAGTTC); Fizz1 (forward primer, 59-
GCCAGGTCCTGGAACCTTTC; reverse primer, 59-GGAG-
CAGGGAGATGCAGATGAG); IL-4 (forward primer, 59-
GTCTGCATCAAGACGCCATG; reverse primer, 59-
CGTTGCTGTGAGGACGTTTG); iNOS (forward primer, 59-
ACCCACATCTGGCAGAATGAG; reverse primer 59-AGC-
CATGACCTTTCGCATTAG); TNF (forward primer, 59-
AGCCGATGGGTTGTACCTTG; reverse primer, 59-
GTGGGTGAGGAGCACGTAGTC); Ym1/Chi3l3
(Mm00657889_mH; purchased from Life Technologies); and IL-
10 (Mm00439614_m1; purchased from Life Technologies) real-
time RT-PCR analyses were carried out by using TaqMan and
the relative expression was calculated by using the DCT method
and normalized to the GADPH housekeeping gene (forward
primer, 59-ATGACCACAGTCCATGCCATC; reverse primer,
59-GAGCTTCCCGTTCAGCTCTG). All qRT-PCRs were per-
formed in triplicate, and the data are presented as mean 6
standard deviations (S.D.).
Statistical Analysis
Student’s t-test and Mann Whitney u-test were used to validate
the significance of the observed differences. A p-value of less than
0.05 was considered statistically significant.
Supporting Information
Figure S1 Comparison of IL-4 (A) and TNF (B) expression at
M0 state in microglia, peritoneal macrophages and bone-marrow
(BM)-derived macrophages in two separate experiments. BM-
derived and peritoneal macrophages were obtained from WT B6
mice as in Fig. 1, while microglial cells were isolated from the CNS
of WT B6 mice as described in Materials and Methods. RNA was
isolated and the expression of mRNA transcripts for IL-4 and
TNF was analyzed by real-time RT PCR as described in Materials
and Methods. Results are shown in duplicates (shown as ‘‘Duplicate
1’’ and ‘‘Duplicate 2’’) for two representative experiments
indicated as ‘#1’ or ‘#2’. Abbreviations: MG, microglia;
Perit.MPh, peritoneal macrophages, BM-MPh, bone marrow
derived macrophages.
(TIF)
Figure S2 Analysis of expression of miR-124 in the ex-
vivo isolated microglia from the CNS of healthy B6-WT,
B6-IL-4 (B6-IL-4 KO) and B6-STAT6 (B6-STAT6 KO)
deficient (knock out) mice, or BALB/c-WT and BALB/c-
IL-4/13R (BALB/c-IL-4/13R KO) deficient mice. Microg-
lia were isolated as described in Materials and Methods and the
expression of miR-124 was analyzed as in Fig. 1. The data is
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